- active not recruiting
LITMUS Imaging Study
This study looks at new ways to check liver health in people with fatty liver disease (NAFLD) without taking a biopsy. It uses special scans to see how well these new checks work compared to traditional methods and how liver disease changes over time.
United States · Finland · France - recruiting
The European NAFLD Registry
This study aims to understand fatty liver disease (NAFLD) better. Researchers collect information and samples from patients across Europe to find new ways to detect and monitor the disease, especially how it progresses from fatty liver to more serious conditions like fibrosis.
Belgium · Finland · France - ongoing, recruitingTherapeutic exploratory (Phase II)
Dasatinib and quercetin, a combination of senolytics to treat fibrotic non-alcoholic fatty liver disease; The TRUTH study
This study, called The TRUTH study, is looking at a combination of two drugs, dasatinib and quercetin, to treat a liver condition called non-alcoholic fatty liver disease (NAFLD) with scarring (fibrosis). Researchers want to see if this treatment can improve liver scarring over 21 weeks.
Netherlands - active not recruitingPHASE2
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
This study is looking into a new medicine called efinopegdutide for a liver condition called MASH. We want to see if it can help reduce liver fat, swelling, and scarring in people with MASH and mild scarring. It also checks how safe the medicine is.
United States · Australia · Canada - recruitingNA
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
This study looks at whether a daily pectin supplement, found in foods like citrus peel, can reduce inflammation and improve gut health in adults with a common liver condition called MASLD. Researchers want to see if it helps with overall health.
United Kingdom